Staff

National Comprehensive Cancer Network(R) Updates Designation of Monjuvi(R) (tafasitamab-cxix) to Preferred Regimen in Its Clinical Practice Guidelines in Oncology for B-cell Lymphomas

TRxADE HEALTH, INC. to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th from 9:00 a.m. – 5:00 p.m. EDT

New H1 Solution Sets Out to Transform How Patients Discover, Evaluate and Engage Doctors, While Helping Payors Solve for Provider Data Inaccuracy

Powered by H1's expansive provider-centric knowledge base, H1 Precise systematically updates and manages provider data for directory accuracy and network...

Revelation Biosciences Inc. Announces Enrollment and Dosing Complete for Phase 2b Viral Challenge Study to Assess Efficacy of Intranasal REVTx 99 for the Prevention of H3N2 Influenza Infection

error: Content is protected !!